Method of Tibiocalcaneal Arthrodesis for a Total Defect of the Talus in Patients with Charcot Neuroarthropathy
- Authors: Osnach S.A.1, Protsko V.G.1,2, Obolenskiy V.N.3,4, Vinogradov V.A.2, Kuznetsov V.V.1, Tamoev S.K.1
-
Affiliations:
- Yudin City Clinical Hospital
- Peoples’ Friendship University of Russia named after Patrice Lumumba
- City Clinical Hospital No 13
- Pirogov Russian National Research Medical University
- Issue: Vol 31, No 1 (2025)
- Pages: 125-132
- Section: Modern technologies in traumatology and orthopedics
- Submitted: 29.08.2024
- Accepted: 16.12.2024
- Published: 12.03.2025
- URL: https://journal.rniito.org/jour/article/view/17605
- DOI: https://doi.org/10.17816/2311-2905-17605
- ID: 17605
Cite item
Abstract
Background. At present, treatment of patients with Charcot neuroarthropathy remains an unsolved problem. The current state of the problem motivated us to develop a new original method of hindfoot reconstruction aimed to form a tibiocalcaneal bone block with maximum possible preservation of limb length in patients with Charcot neuroarthropathy.
The aim of the paper was to demonstrate a new one-stage tibiocalcaneal arthrodesis technique aimed at preserving maximum possible limb length.
Surgical technique description. At the preoperative stage, the angle adjacent to the Gissan angle and its bisector is measured on X-rays. After performing the Kocher ankle approach with subsequent lateral malleolus resection and osteonecrectomy, the distal metaepiphysis of the tibia is cut in an oblique-horizontal plane at the bisector angle, open posteriorly and equal to the preoperatively measured value. The resulting triangular bone fragment is rotated by 180º and adapted within the external fixator.
Conclusion. The proposed method for total talar destruction in patients with Charcot neuroarthropathy is convenient and simple for adapting incongruent calcaneal and tibial surfaces and allows reducing the lower limb shortening in tibiocalcaneal arthrodesis.
Full Text
INTRODUCTION
Charcot neuroarthropathy (Charcot foot) is a condition characterized by damage to the bones, joints, and soft tissues of the foot and ankle. Although it can develop in case of various peripheral neuropathies, diabetic neuropathy is the most common cause. Several factors contribute to its pathogenesis, including diabetic sensorimotor neuropathy, autonomic neuropathy, trauma, and metabolic disorders of bone tissue. The interaction of these factors leads to local inflammation, which subse-quently causes bone destruction, subluxations, dislocations, and limb deformities [1].
A literature review reveals that the management of patients with Charcot neuro-arthropathy remains an unresolved issue. Despite numerous treatment approaches, none fully satisfy the authors and other specialists. Conservative treatment is essential but does not provide lasting orthopedic correction, nor does it eliminate the risks of secondary foot deformities or trophic soft tissue lesions [2, 3, 4]. The goal of surgical treatment in patients with complicated diabetic neuroarthropathy is the radical removal of bone destruction foci, correction of deformities and removal of osteophytes that contribute to trophic ulcer formation, and the subsequent functional recovery of the foot through optimal anatomical reconstruction, rational restoration of segment length and biomechanics [5, 6, 7]. Restoring weight-bearing capacity and preserving limb length remain clinically challenging. Existing Charcot foot reconstruction techniques have high complication and recurrence rates with controversial clinical outcomes [8, 9].
Tibiocalcaneal arthrodesis using an intramedullary locking nail is a relatively success-ful surgical approach [10, 11], with a bone union rate of up to 75% in diabetic patients [12]. Two-stage arthrodesis techniques with defect reconstruction using a free autograft offer significant advantages for correcting absolute segment shortening and improving graft integration but require a second surgical procedure and prolonged fixation [13]. Some cases report foot reconstruction with a heterotopic allograft from the femoral head followed by arthrodesis with locking nail [14, 15, 16]. The use of additive manufacturing technologies to replace talar bone defects in tibiocalcaneal arthrodesis with titanium implants, supplemented with autografts or allografts, has been described in the literature [9, 17]. The advantage of this technique is the ability to create custom-made implants based on CT scans, minimizing the need for calcaneal and tibial bone resection, reducing limb shortening, and decreasing the risk of auto- or allograft collapse during implant integration [18].
Unfortunately, reconstructive operations or ankle and subtalar arthrodesis with the complete preservation of limb length are not feasible. Talectomy with tibiocalcaneal arthrodesis using an external fixator is an effective reconstruction method for restoring weight-bearing capacity, especially in patients with concomitant osteo-penia and vitamin D deficiency [19]. However, limb shortening in tibiocalcaneal arthrodesis occurs not only due to the talar bone removal but also because of the resection of the tibial and, predominantly, calcaneal bone ends to achieve surface congruence. According to R. Rochman et al., the average limb shortening after tibiocalcaneal arthrodesis was 4 cm (ranging from 2.5 to 5 cm) [8].
Current challenges in treating Charcot neuroarthropathy motivated us to develop a novel reconstruction technique for the hindfoot to form a tibiocalcaneal bone block while preserving maximal limb length in patients with Charcot neuroarthropathy.
The aim of the paper was to demonstrate a new one-stage tibiocalcaneal arthrodesis technique aimed at preserving maximum possible limb length.
SURGICAL TECHNIQUE
During preoperative planning, radiographic measurements include the angle adjacent to the Gissane angle, and its bisector. Intraoperatively, with the patient in the supine position, after antiseptic preparation and placement of a pneumatic tourniquet on the lower third of the thigh, the Kocher ankle approach is performed with subsequent lateral malleolus resection. The destruction site is assessed, followed by the removal of deformed and affected talar bone fragments, scar tissue, and pathological granulations, as well as synovectomy, and articular cartilage resection.
Next, an extrafocal osteosynthesis is performed using a compression-distraction external fixator consisting of two rings fixed to the tibia and two half-rings fixed to the foot (one posteriorly and one anteriorly). Wires are placed in an oblique-frontal plane at the projection of the rings and half-rings and are fixed in the plane of the rings using wire tensioners. Half-rings are connected via threaded rods and one- or two-plane hinges. The distal metaepiphysis of the tibia is cut in an oblique-horizontal plane at the bisector angle, open posteriorly and equal to the preoperatively measured value. The resulting triangular bone fragment is rotated 180° and adapted to the surrounding bone structures within the external fixator. Fixation continues until stable tibiocalcaneal bone block is formed. The surgical stages are illustrated in Figure 1.
Figure 1. Schematic representation of the surgery stages: a — destruction of the talus; b — resection of the articular surfaces of both the distal tibial and calcaneal metaepiphysis; c — markings performed; d — sawing of the posterior edge of the tibia with the isolation of a wedge-shaped graft; e — turning the graft by 180º for better adaptation of the fragments
Using this method, 11 patients were treated at the Foot and Diabetic Foot Surgery Center of Yudin City Clinical Hospital between 2021 and 2023. Among them, 6 patients (54.5%) had type 2 diabetes, 4 patients (36.4%) had type 1 diabetes, and 1 patient (9.1%) had distal neuropathy without diabetes. The cohort included 9 women (82%) and 2 men (18%), with an average age of 53.4±3.8 years (range: 30-72). The follow-up period exceeded one year.
The average duration of external fixation was 6.4±0.2 months (5.5-7.0 months). There were no cases of infection, nonunion, or wire-associated osteomyelitis.
We present the use of this technique in a clinical case of a 72-year-old female patient with distal neuropathy without diabetes. A year before seeking treatment, she noticed progressive left foot deformity, was observed on an outpatient basis. Conservative treatment and orthotic use for one year yielded no improvement (Figure 2).
Figure 2. Photograph and X-ray of the foot and ankle joint before inpatient treatment
The patient underwent the described resectional tibiocalcaneal arthrodesis at the Foot Surgery Center of Yudin Hospital, with subsequent external fixation for seven months (Figure 3). After Ex-Fix removal, rehabilitation involved gradual weight-bearing in an immobilizing ankle brace with an air chamber for 10 months, followed by a transition to custom-made orthopedic footwear with a rocker bottom sole. The treatment outcome at 1.5 years is shown in Figure 4.
Figure 3. Stages of surgical intervention: a — intraoperative X-ray — fragments adaptation; b — photograph of the wedge-shaped bone graft; c — X-ray after installation of the wedge-shaped autograft
Figure 4. X-ray and photograph of the patient’s feet and ankle joints 1.5 years after dismantling the external fixation device
DISCUSSION
According to L.I. Sanders and R.G. Frykberg, Charcot neuroarthropathy affects the ankle and subtalar joints (Sanders types 4 and 5) in up to 10% of cases [20]. This region is particularly important due to the unique vascular supply of the talus, increased risk of avascular necrosis, and critical functional role in weight-bearing. Although talus involvement in Charcot neuroarthropathy is less common than that of Lisfranc and Chopart joints (27.60% and 30.35%, respectively), the pathologic process in the ankle joint is more severe [21]. Patients with distal neuropathy continue full weight-bearing on the compromised limb, which leads to pathologic fractures, particularly of the talus. In diabetic neuroarthropathy, dysregulation of the RANKL-RANK-OPG system contributes to osteoclast hyperactivity and subsequent bone resorption. Additionally, increased inflammatory cytokine levels exacerbate RANKL activation, reducing bone repair capacity and accelerating bone destruction [22, 23]. This results in total or subtotal talar defects, multiplanar deformities, and ankle instability [24], leading to non-weight-bearing and necessitating surgical intervention.
Despite numerous fixation techniques, single-stage reconstructions remain relevant for patients unwilling to undergo prolonged multi-stage procedures for limb length restoration.
Our technique for total talar destruction in Charcot neuroarthropathy is more convenient, facilitating better adaptation of incongruent calcaneal and tibial surfaces in tibiocalcaneal arthrodesis. This method is patented (RF Patent No 2782784, 02.11.22, “The method of tibiocalcaneal arthrodesis for Charcot neuroarthropathy”).
We consider this technique the method of choice for Sanders types 4 and 5 Charcot neuroarthropathy, allowing single-stage surgical correction while maximizing calcaneal bone preservation without additional bone grafting or extended duration of fixation.
Currently, when analyzing the outcomes of using external fixators to achieve stable arthrodesis, it is not possible to formulate an evidence-based standard protocol that reliably determines the duration of external fixation, functional weight-bearing regimens and terms, or the specifics of orthotic support.
The introduction of the hindfoot reconstruction technique in clinical practice to form a tibiocalcaneal bone block is one of the effective and technically simple options for restoring limb weight-bearing capacity in patients with Charcot neuroarthropathy.
CONCLUSION
The proposed method of tibiocalcaneal arthrodesis for severe hindfoot bone defects represents a simple and practical surgical solution. We hope our experience will be of interest to specialists in foot reconstruction, including those performing transosseous osteosynthesis. In our opinion, this approach has strong potential for clinical implementation as an alternative to existing techniques for treating Charcot neuroarthropathy.
DISCLAIMERS
Author contribution
All authors made equal contributions to the study and the publication.
All authors have read and approved the final version of the manuscript of the article. All authors agree to bear responsibility for all aspects of the study to ensure proper consideration and resolution of all possible issues related to the correctness and reliability of any part of the work.
Funding source. This study was not supported by any external sources of funding.
Disclosure competing interests. The authors declare that they have no competing interests.
Ethics approval. The study was performed on the basis of ethical principles of the World Medical Association’s Declaration of Helsinki (2013), “Good Clinical Practice in the Russian Federation” approved by the order of the Ministry of Health of the Russian Federation from 19.06.2003 No 266.
Consent for publication. Written consent was obtained from the patient for publication of relevant medical information and all of accompanying images within the manuscript.
About the authors
Stanislav A. Osnach
Yudin City Clinical Hospital
Email: stas-osnach@yandex.ru
ORCID iD: 0000-0003-4943-3440
Россия, Moscow
Victor G. Protsko
Yudin City Clinical Hospital; Peoples’ Friendship University of Russia named after Patrice Lumumba
Email: 89035586679@mail.ru
ORCID iD: 0000-0002-5077-2186
Dr. Sci. (Med.)
Россия, Moscow; MoscowVladimir N. Obolenskiy
City Clinical Hospital No 13; Pirogov Russian National Research Medical University
Email: gkb13@mail.ru
ORCID iD: 0000-0003-1276-5484
Cand. Sci. (Med.)
Россия, Moscow; MoscowVladimir A. Vinogradov
Peoples’ Friendship University of Russia named after Patrice Lumumba
Email: vovavin15@gmail.com
ORCID iD: 0000-0001-5228-5130
Россия, Moscow
Vasiliy V. Kuznetsov
Yudin City Clinical Hospital
Email: vkuznecovniito@gmail.com
ORCID iD: 0000-0001-6287-8132
Cand. Sci. (Med.)
Россия, MoscowSargon K. Tamoev
Yudin City Clinical Hospital
Author for correspondence.
Email: sargonik@mail.ru
ORCID iD: 0000-0001-8748-0059
Cand. Sci. (Med.)
Россия, MoscowReferences
- Rogers L.C., Frykberg R.G., Armstrong D.G., Boulton A.J., Edmonds M., Van G.H. et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129. doi: 10.2337/dc11-0844.
- Gratwohl V., Jentzsch T., Schöni M., Kaiser D., Berli M.C., Böni T. et al. Long-term follow-up of conservative treatment of Charcot feet. Arch Orthop Trauma Surg. 2022;142(10):2553-2566. doi: 10.1007/s00402-021-03881-5.
- Blume P.A., Sumpio B., Schmidt B., Donegan R. Charcot neuroarthropathy of the foot and ankle: diagnosis and management strategies. Clin Podiatr Med Surg. 2014;31(1):151-172. doi: 10.1016/j.cpm.2013.09.007.
- Sticha R.S., Frascone S.T., Wertheimer S.J. Major arthrodeses in patients with neuropathic arthropathy. J Foot Ankle Surg. 1996;35(6):560-566. doi: 10.1016/s1067-2516(96)80130-x.
- Zgonis T., Stapleton J.J., Jeffries L.C., Girard-Powell V.A., Foster L.J. Surgical treatment of Charcot neuropathy. AORN J. 2008;87(5):971-990. doi: 10.1016/j.aorn.2008.03.002.
- Pinzur M.S. Surgical treatment of the Charcot foot. Diabetes Metab Res Rev. 2016;32 Suppl 1:287-291. doi: 10.1002/dmrr.2750.
- Stuto A.C., Stapleton J.J. Surgical Considerations for the Acute and Chronic Charcot Neuroarthropathy of the Foot and Ankle. Clin Podiatr Med Surg. 2022;39(2):331-341. doi: 10.1016/j.cpm.2021.11.005.
- Rochman R., Jackson Hutson J., Alade O. Tibiocalcaneal arthrodesis using the Ilizarov technique in the presence of bone loss and infection of the talus. Foot Ankle Int. 2008;29(10):1001-1008. doi: 10.3113/FAI.2008.1001.
- Steele J.R., Kadakia R.J., Cunningham D.J., Dekker T.J., Kildow B.J., Adams S.B. Comparison of 3D Printed Spherical Implants versus Femoral Head Allografts for Tibiotalocalcaneal Arthrodesis. J Foot Ankle Surg. 2020;59(6):1167-1170. doi: 10.1053/j.jfas.2019.10.015.
- Love B., Alexander B., Ray J., Halstrom J., Barranco H., Solar S. et al. Outcomes of Tibiocalcaneal Arthrodesis in High-Risk Patients: An Institutional Cohort of 18 Patients. Indian J Orthop. 2020;54(1):14-21. doi: 10.1007/s43465-020-00048-z.
- Caravaggi C.M., Sganzaroli A.B., Galenda P., Balaudo M., Gherardi P., Simonetti D. et al. Long-term follow-up of tibiocalcaneal arthrodesis in diabetic patients with early chronic Charcot osteoarthropathy. J Foot Ankle Surg. 2012;51(4):408-411. doi: 10.1053/j.jfas.2012.04.007.
- Vitiello R., Perna A., Peruzzi M., Pitocco D., Marco G. Clinical evaluation of tibiocalcaneal arthrodesis with retrograde intramedullary nail fixation in diabetic patients. Acta Orthop Traumatol Turc. 2020;54(3):255-261. doi: 10.5152/j.aott.2020.03.334.
- Оснач С.А., Оболенский В.Н., Процко В.Г., Борзунов Д.Ю., Загородний Н.В., Тамоев С.К. Метод двухэтапного лечения пациентов с тотальными и субтотальными дефектами стопы при нейроостеоартропатии Шарко. Гений ортопедии. 2022;28(4): 523-531. doi: 10.18019/1028-4427-2022-28-4-523-531. Оsnach S., Obolensky V., Protsko V., Borzunov D., Zagorodniy N., Tamoev S. Method of two-stage treatment of total and subtotal defects of the foot in Charcot neuroosteoarthropathy. Genij Ortopedii. 2022;28(4):523-531. (In Russian). doi: 10.18019/1028-4427-2022-28-4-523-531.
- Berkowitz M.J., Clare M.P., Walling A.K., Sanders R. Salvage of failed total ankle arthroplasty with fusion using structural allograft and internal fixation. Foot Ankle Int. 2011;32(5):S493-502. doi: 10.3113/FAI.2011.0493.
- Jeng C.L., Campbell J.T., Tang E.Y., Cerrato R.A., Myerson M.S. Tibiotalocalcaneal arthrodesis with bulk femoral head allograft for salvage of large defects in the ankle. Foot Ankle Int. 2013;34(9):1256-1266. doi: 10.1177/1071100713488765.
- Clowers B.E., Myerson M.S. A novel surgical technique for the management of massive osseous defects in the hindfoot with bulk allograft. Foot Ankle Clin. 2011;16(1):181-189. doi: 10.1016/j.fcl.2010.12.005.
- Ramhamadany E., Chadwick C., Davies M.B. Treatment of Severe Avascular Necrosis of the Talus Using a Novel Keystone-Shaped 3D-Printed Titanium Truss Implant. Foot Ankle Orthop. 2021;6(4):24730114211043516. doi: 10.1177/24730114211043516.
- LaPorta G.A., Nasser E.M., Mulhern J.L. Tibiocalcaneal arthrodesis in the high-risk foot. J Foot Ankle Surg. 2014;53(6):774-786. doi: 10.1053/j.jfas.2014.06.027.
- Yoho R.M., Frerichs J., Dodson N.B., Greenhagen R., Geletta S. A comparison of vitamin D levels in nondiabetic and diabetic patient populations. J Am Podiatr Med Assoc. 2009;99(1):35-41. doi: 10.7547/0980035.
- Sanders L.I., Frykberg R.G. The Charcot foot. In: Levin and O’Neal’s The Diabetic Foot. 7th edn. Philadelphia: Mosby Elsevier; 2007. 258 p.
- Trepman E., Nihal A., Pinzur M.S. Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005;26(1):46-63. doi: 10.1177/107110070502600109.
- Ndip A., Williams A., Jude E.B., Serracino-Inglott F., Richardson S., Smyth J.V. et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60(8): 2187-2196. doi: 10.2337/db10-1220.
- Kaynak G., Birsel O., Güven M.F., Oğüt T. An overview of the Charcot foot pathophysiology. Diabet Foot Ankle. 2013;4. doi: 10.3402/dfa.v4i0.21117.
- Wukich D.K., Raspovic K.M., Hobizal K.B., Sadoskas D. Surgical management of Charcot neuroarthropathy of the ankle and hindfoot in patients with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:292-296. doi: 10.1002/dmrr.2748.
Supplementary files
